Identification of a novel organic anion transporter mediating carnitine transport in mouse liver and kidney

Cellular Physiology and Biochemistry

Volumn 25, Issue 4-5, 2010, Pages 511-522

  Tsuchida, Hiroki ^a,b   Anzai, Naohiko ^a   Shin, Ho J ^a   Wempe, Michael F ^c   Jutabha, Promsuk ^a   Enomoto, Atsushi ^a   Cha, Seok H ^a   Satoh, Takeo ^b   Ishida, Masashi ^b   Sakurai, Hiroyuki ^a   Endou, Hitoshi ^a  

^a KYORIN UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

Carnitine; Organic anion transport; Renal tubular epithelial cells; Zwitterions

Indexed keywords

AMPHOLYTE; CARNITINE; CIMETIDINE; ORGANIC ANION TRANSPORTER; ORGANIC ANION TRANSPORTER 9L; ORGANIC ANION TRANSPORTER 9S; SALICYLIC ACID; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; HYDROPHOBICITY; KIDNEY PROXIMAL TUBULE; LIVER CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OOCYTE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; STRUCTURE ACTIVITY RELATION; XENOPUS LAEVIS;

AVENA;

EID: 77949922736     PISSN: 10158987     EISSN: None     Source Type: Journal    
DOI: 10.1159/000303060     Document Type: Article

References (51)

1. Pritchard JB, Miller DS: Mechanisms mediating renal secretion of organic anions and cations. Physiol Rev 1993;73:765-796.
2. Rizwan AN, Burckhardt G: Organic anion transporters of the SLC22 family: biopharmaceutical, physiological, and pathological roles. Pharm Res 2007;24:450-470.
3. Nigam SK, Bush KT, Bhatnagar V: Drug and toxicant handling by the OAT organic anion transporters in the kidney and other tissues. Nat Clin Pract Nephrol 2007;3:443-447.
4. Burckhardt G, Wolff NA: Structure of renal organic anion and cation transporters. Am J Physiol Renal Physiol 2000;278:F853-F866.
5. Koepsell H, Endou H: The SLC22 drug transporter family. Pflugers Arch 2004;447:666-676.
6. Gründemann D, Gorboulev V, Gambaryan S, Veyhl M, Koepsell H: Drug excretion mediated by a new prototype of polyspecific transporter. Nature 1994;372:549-552.
7. Okuda M, Saito H, Urakami Y, Takano M, Inui K-I: cDNA cloning and functional expression of a novel rat kidney organic cation transporter, OCT2. Biochem Biophys Res Commun 1996;224:500-507.
8. Kekuda R, Prasad PD, Wu X, Wang H, Fei Y-J, Leibach FH, Ganapathy V: Cloning and functional characterization of a potential-sensitive, polyspecific organic cation transporter (OCT3) most abundantly expressed in placenta. J Biol Chem 1998;273:15971-15979.
9. Tamai I, Yabuuchi H, Nezu J-I, Sai Y, Oku A, Shimane M, Tsuji A: Cloning and characterization of a novel human pH-dependent organic cation transporter, OCTN1. FEBS Lett 1997;419:107-111.
10. Wu X, Prasad PD, Leibach FH, Ganapathy V: cDNA sequence, transport function, and genomic organization of human OCTN2, a new member of the organic cation transporter family. Biochem Biophys Res Commun 1998;246:589-595.
11. Tamai I, Ohashi R, Nezu J-I, Sai Y, Kobayashi D, Oku A, Shimane M, Tsuji A: Molecular and functional characterization of organic cation/ carnitine transporter family in mice. J Biol Chem 2000;275:40064-40072.
12. Tamai I, Ohashi R, Nezu J-I, Yabuuchi H, Oku A, Shimane M, Sai Y, Tsuji A: Molecular and functional identification of sodium-ion-dependent, high affinity human carnitine transporter OCTN2. J Biol Chem 1998;273:20378-20382.
13. Wu X, Huang W, Prasad PD, Seth P, Rajan DP, Leibach FH, Chen J, Conway SJ, Ganapathy V: Functional characterization and tissue distribution pattern of organic cation transporter 2 (OCTN2), an organic cation/carnitine transporter. J Pharmacol Exp Ther 1999;290:1482-1492.
14. Sekine T, Kusuhara H, Utsunomiya-Tate N, Tsuda M, Sugiyama Y, Kanai Y, Endou H: Molecular cloning and characterization of high-affinity carnitine transporter from rat intestine. Biochem Biophys Res Commun 1998;251:586-591.
15. Wagner CA, Lükewille U, Kaltenbach S, Moschen I, Bröer A, Risler T, Bröer S, Lang F: Functional and pharmacological characterization of human Na+-carnitine cotransporter hOCTN2. Am J Physiol Renal Physiol 2000;279:F584-F591.
16. Bremer J: Carnitine-metabolism and functions. Physiol Rev 1983;63:1420-1480.
17. Carter AL, Abney TO, Lapp DF: Biosynthesis and metabolism of carnitine. J Child Neurol 1995;10:3-7.
18. Nezu J-I, Tamai I, Oku A, Ohashi R, Yabuuchi H, Hashimoto N, Nikaido H, Sai Y, Koizumi A, Shoji Y, Takada G, Matsuishi T, Yoshino M, Kato H, Ohura T, Tsujimoto G, Hayakawa J-I, Shimane M, Tsuji A: Primary systemic carnitine deficiency is caused by mutations in a gene encoding sodium ion-dependent carnitine transporter. Nat Genet 1999;21:91-94.
19. Enomoto A, Wempe MF, Tsuchida H, Shin HJ, Cha SH, Anzai N, Goto A, Sakamoto A, Niwa T, Kanai Y, Anders MW, Endou H: Molecular identification of a novel carnitine transporter specific to human testis: Insights into the mechanism of carnitine recognition. J Biol Chem 2002;277:36262-36271.
20. Anzai N, Kanai Y, Endou H: Organic Anion Transporter Family: Current Knowledge. J Pharmacol Sci 2006;100:411-426.
21. Sekine T, Watanabe N, Hosoyamada M, Kanai Y, Endou H: Expression cloning and characterization of a novel multispecific organic anion transporter. J Biol Chem 1997;272:18526-18529.
22. Sweet DH, Wolff NA, Pritchard JB: Expression cloning and characterization of ROAT1. The basolateral organic anion transporter in rat kidney. J Biol Chem 1997;272:30088-30095.
23. Sekine T, Cha SH, Tsuda M, Apiwattanakul N, Nakajima N, Kanai Y, Endou H: Identification of multispecific organic anion transporter 2 expressed predominantly in the liver. FEBS Lett 1998;429:179-182
24. Kusuhara H, Sekine T, Utsunomiya-Tate N, Tsuda M, Kojima R, Cha SH, Sugiyama Y, Kanai Y, Endou H: Molecular cloning and characterization of a new multispecific organic anion transporter from rat brain. J Biol Chem 1999;274:13675-13680.
25. Cha SH, Sekine T, Kusuhara H, Yu E, Kim JY, Kim DK, Sugiyama Y, Kanai Y, Endou H: Molecular cloning and characterization of multispecific organic anion transporter 4 expressed in the placenta. J Biol Chem 2000;275:4507-4512.
26. Youngblood GL, Sweet DH: Identification and functional assessment of the novel murine organic anion transporter Oat5 (Slc22a19) expressed in kidney. Am J Physiol Renal Physiol 2004;287:F236-F244.
27. Monte JC, Nagle MA, Eraly SA, Nigam SK: Identification of a novel murine organic anion transporter family member, OAT6, expressed in olfactory mucosa. Biochem Biophys Res Commun 2004;323:429-436.
28. Shin HJ, Anzai N, Enomoto A, He X, Kim DK, Endou H, Kanai Y: Novel liver-specific organic anion transporter OAT7 that operates the exchange of sulfate conjugates for short chain fatty acid butyrate. Hepatology 2007;45:1046-1055
29. Yokoyama H, Anzai N, Ljubojevic M, Ohtsu N, Sakata T, Miyazaki H, Nonoguchi H, Islam R, Onozato M, Tojo A, Tomita K, Kanai Y, Igarashi T, Sabolic I, Endou H: Cell Physiol Biochem 2008;21:269-278.
30. Enomoto A, Kimura H, Chairoungdua A, Shigeta Y, Jutabha P, Cha SH, Hosoyamada M, Takeda M, Sekine T, Igarashi T, Matsuo H, Kikuchi Y, Oda T, Ichida K, Hosoya T, Shimokata K, Niwa T, Kanai Y, Endou H: Molecular identification of a renal urate-anion exchanger that regulates blood urate levels. Nature 2002;417:447-452.
31. Nilwarangkoon S, Anzai N, Shiraya K, Yu E, Islam R, Cha SH, Onozato ML, Miura D, Jutabha P, Tojo A, Kanai Y, Endou H: Role of mouse organic anion transporter 3 (mOat3) as a basolateral prostaglandin E2 transport pathway. J Pharmacol Sci 2007;103:48-55.
32. Islam R, Anzai N, Ahmed N, Ellapan B, Jin CJ, Srivastava S, Miura D, Fukutomi T, Kanai Y, Endou H: Mouse organic anion transporter 2 (mOat2) mediates the transport of short chain fatty acid propionate. J Pharmacol Sci 2008;106:525-528.
33. Takeda M, Narikawa S, Hosoyamada M, Sekine T, Cha SH, Endou H: Characterization of organic anion transport inhibitors using cells stably expressing human organic anion transporters. Eur J Pharmacol 2001;419:113-120
34. Enomoto A, Takeda M, Shimoda M, Narikawa S, Kobayashi Y, Kobayashi Y, Yamamoto T, Sekine T, Cha SH, Niwa T, Endou H: Interaction of human organic anion transporters 2 and 4 with organic anion transport inhibitors. J Pharmacol Exp Ther 2002;301:797-802.
35. Tream WR, Stanley CA, Finegold DN, Hale DE, Coates PM: Primary carnitine deficiency due to a failure of carnitine transport in kidney, muscle, and fibroblasts. N Engl J Med 1988;17:1331-1336.
36. Shaw RD, Li BUK, Hamilton JW, Shug AL, Olsen WA: Carnitine transport in rat small intestine. Am J Physiol 1983;245:G376-G381.
37. Gross CJ, Henderson LM: Absorption of D-and L-carnitine by the intestine and kidney tubule in the rat. Biochim Biophys Acta 1984;772:209-219.
38. Huth PJ, Shug AL: Properties of carnitine transport in rat kidney cortex slices. Biochem Biophys Acta 1980;602:621-634.
39. Rebouche CJ, Mack DL: Sodium gradient-stimulated transport of L-carnitine into renal brush border membrane vesicles: kinetics, specificity, and regulation by dietary carnitine. Arch Biochem Biophys 1984;235:393-402.
40. Stieger B, O'Neill B, Krähenbühl S: Characterization of L-carnitine transport by rat kidney brush-border membrane vesicles. Biochem J 1995;309:643-647.
41. Christiansen RZ, Bremer J: Active transport of butyrobetaine and carnitine into isolated liver cells. Biochim Biophys Acta 1976;448:562-577.
42. Brass EP, Hoppel CL: Carnitine metabolism in the fasting rat. J Biol Chem 1978;253:2688-2693.
43. Seth P, Wu X, Huang W, Leibach FH, Ganapathy V: Mutations in novel organic cation transporter (OCTN2), an organic cation/carnitine transporter, with differential effects on the organic cation transport function and the carnitine transport function. J Biol Chem 1999;274:33388-33392.
44. Hashimoto N, Suzuki F, Tamai I, Nikaido H, Kuwajima M, Hayakawa J, Tsuji A: Gene-dose effect on carnitine transport activity in embryonic fibroblasts of JVS mice as a model of human carnitine transporter deficiency. Biochem Pharmacol 1998;55:1729-1732.
45. Tamai I, China K, Sai Y, Kobayashi D, Nezu J-I, Kawahara E, Tsuji A: Na+-coupled transport of L-carnitine via high-affinity carnitine transporter OCTN2 and its subcellular localization in kidney. Biochim Biophys Acta 2001;1512:273-284.
46. Urakami Y, Akazawa M, Saito H, Okuda M, Inui I-K: cDNA cloning, functional characterization, and tissue distribution of an alternatively spliced variant of organic cation transporter hOCT2 predominantly expressed in the human kidney. J Am Soc Nephrol 2002;13:1703-1710.
47. Masuda S, Ibaramoto K, Takeuchi A, Saito H, Hashimoto Y, Inui K-I: Cloning and functional characterization of new multispecific organic anion transporter, OAT-K2, in rat kidney. Mol Pharmacol 1999;55:743-752.
48. Ullrich KJ, Rumrich G, David C, Fritzsch G: Bisubstrates: substances that interact with renal contraluminal organic anion and organic cation transport systems. I. Amines, piperidines, piperazines, azepines, pyridines, quinolines, imidazoles, thiazoles, guanidines and hydrazines. Pflügers Arch 1993;425:280-299.
49. Ullrich KJ, Rumrich G, David C, Fritzsch G: Bisubstrates: substances that interact with both, renal contraluminal organic anion and organic cation transport systems. II. Zwitterionic substrates: dipeptides, cephalosporins, quinolone-carboxylate gyrase inhibitors and phosphamide thiazine carboxylates; nonionizable substrates: steroid hormones and cyclophosphamides. Pflügers Arch 1993;425:300-312.
50. Ohashi R, Tamai I, Yabuuchi H, Nezu J-I, Oku A, Sai Y, Shimane M, Tsuji A: Na(+)-dependent carnitine transport by organic cation transporter (OCTN2): its pharmacological and toxicological relevance. J Pharmacol Exp Ther 1999;291:778-784.
51. Ullrich KJ: Renal transporters for organic anions and organic cations. Structural requirements for substrates. J Membr Biol 1997;158:95-107.